mounjaro 2.5 mg

Mounjaro 2.5 mg – Once-Weekly Tirzepatide Injection for Type 2 Diabetes

Mounjaro 2.5 mg is a prescription medication that contains tirzepatide, a first-in-class, once-weekly injectable therapy designed to improve blood sugar control in adults with type 2 diabetes. Developed by Eli Lilly, Mounjaro combines dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist actions to target key pathways involved in blood sugar regulation.

This 2.5 mg dose is typically used as the starting dose in a titration plan that gradually increases to higher strengths, allowing the body to adjust to treatment and minimize gastrointestinal side effects.

Key Benefits:

• Dual-action therapy: Activates both GIP and GLP-1 receptors to improve insulin sensitivity and reduce glucose levels.

• Weight reduction: Many patients experience weight loss as an added benefit.

• Once-weekly dosing: Convenient pre-filled pen makes adherence easier and lifestyle-friendly.

• Clinically proven: Demonstrated significant improvements in HbA1c levels in clinical trials.

Who It’s For:

Mounjaro 2.5 mg is indicated for adults with type 2 diabetes as part of a complete treatment plan that may include diet and exercise. It is not for use in patients with type 1 diabetes or for those with a history of pancreatitis.

How to Use:

Inject Mounjaro 2.5 mg under the skin (subcutaneously) in the thigh, abdomen, or upper arm once a week. Rotate injection sites each week. Always follow the dosage and schedule prescribed by your healthcare provider.

Safety Information:

Before using Mounjaro, inform your doctor about any other medical conditions, especially if you have a history of:

• Thyroid cancer or thyroid nodules

• Pancreatitis

• Kidney disease

• Gastrointestinal issues

Common side effects may include nausea, diarrhea, decreased appetite, and abdominal discomfort.

Storage Instructions:

Store Mounjaro in the refrigerator (36°F–46°F / 2°C–8°C). Do not freeze. If needed, it can be kept at room temperature (up to 86°F / 30°C) for a total of 21 days.